Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sanara MedTech Inc.SMTI · Entity 5880 | Director | June 04, 2026 | June 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sanara MedTech Inc.
Report date June 04, 2026 · Filed June 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,858 |
Reported balance
After 2026-06-04 transaction · row 1
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 4,154 · Balance 26,858 F1: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 6, 2026 00:31 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 4,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-027592 · ownership.xml · nonDerivative · entry 1 Salamone Ann Beal · CIK 0001799659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,858 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date. Read SEC document |
| May 22, 2025 Filed May 27, 2025 22:10 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 2,809 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-012551 · ownership.xml · nonDerivative · entry 1 Salamone Ann Beal · CIK 0001799659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,704 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The shares of restricted stock will vest on the earlier of (i) the date of the 2026 annual shareholder meeting or (ii) May 22, 2026, provided that the reporting person is providing certain services to the Company through such date. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 21:46 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 2,949 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-023962 · ownership.xml · nonDerivative · entry 1 Salamone Ann Beal · CIK 0001799659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,895 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 12, 2025, provided that the reporting person is providing certain services to the Company through such date. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 23:22 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 2,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-020177 · ownership.xml · nonDerivative · entry 1 Salamone Ann Beal · CIK 0001799659 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,946 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the earlier of (i) the date of the 2024 annual shareholder meeting or (ii) June 1, 2024, provided that the reporting person is providing certain services to the Company on such date. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 21:59 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 4,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-018948 · ownership.xml · nonDerivative · entry 1 Salamone Ann Beal · CIK 0001799659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,544 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on June 10, 2023, provided that the reporting person is providing certain services to the Company on such date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:49 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 1,912 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-004124 · ownership.xml · nonDerivative · entry 3 Salamone Ann Beal · CIK 0001799659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,431 F2 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The shares of restricted stock will vest on the date of the Company's 2022 annual meeting of shareholders; provided that the reporting person is providing services to the Company until such date. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:49 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 3,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-004124 · ownership.xml · nonDerivative · entry 2 Salamone Ann Beal · CIK 0001799659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,519 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:49 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 2,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-004124 · ownership.xml · nonDerivative · entry 1 Salamone Ann Beal · CIK 0001799659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,694 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Company") to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. All of the shares of restricted stock vested on February 9, 2022. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 16:20 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 2,410 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000054 · edgar.xml · nonDerivative · entry 1 Salamone Ann Beal · CIK 0001799659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,410 Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 14:52 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | OtherCommon Stock | 2,410 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897423-20-000044 · edgar.xml · nonDerivative · entry 1 Salamone Ann Beal · CIK 0001799659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 2,410 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock. F1 · price: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 2,410 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 22:12 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 2,410 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000021 · edgar.xml · nonDerivative · entry 1 Salamone Ann Beal · CIK 0001799659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,410 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.